- Home
- FMS vs TOL Comparison
FMS vs TOL Comparison
Compare FMS & TOL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FMS
- TOL
- Stock Information
- Founded
- FMS 1996
- TOL 1967
- Country
- FMS Germany
- TOL United States
- Employees
- FMS N/A
- TOL N/A
- Industry
- FMS Misc Health and Biotechnology Services
- TOL Homebuilding
- Sector
- FMS Health Care
- TOL Consumer Discretionary
- Exchange
- FMS Nasdaq
- TOL Nasdaq
- Market Cap
- FMS 15.0B
- TOL 13.8B
- IPO Year
- FMS 1996
- TOL N/A
- Fundamental
- Price
- FMS $24.72
- TOL $141.66
- Analyst Decision
- FMS Sell
- TOL Buy
- Analyst Count
- FMS 2
- TOL 15
- Target Price
- FMS $30.00
- TOL $150.80
- AVG Volume (30 Days)
- FMS 296.9K
- TOL 1.8M
- Earning Date
- FMS 11-04-2025
- TOL 08-19-2025
- Dividend Yield
- FMS 2.31%
- TOL 0.71%
- EPS Growth
- FMS 23.39
- TOL N/A
- EPS
- FMS 2.62
- TOL 13.61
- Revenue
- FMS $22,922,038,756.00
- TOL $10,876,787,000.00
- Revenue This Year
- FMS $2.10
- TOL $0.41
- Revenue Next Year
- FMS $3.13
- TOL N/A
- P/E Ratio
- FMS $18.65
- TOL $10.42
- Revenue Growth
- FMS 0.53
- TOL 3.26
- 52 Week Low
- FMS $18.94
- TOL $86.67
- 52 Week High
- FMS $30.46
- TOL $169.52
- Technical
- Relative Strength Index (RSI)
- FMS 45.19
- TOL 57.68
- Support Level
- FMS $24.76
- TOL $142.33
- Resistance Level
- FMS $25.33
- TOL $147.49
- Average True Range (ATR)
- FMS 0.30
- TOL 3.30
- MACD
- FMS 0.05
- TOL -0.41
- Stochastic Oscillator
- FMS 33.00
- TOL 42.83
About FMS Fresenius Medical Care AG
Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.
About TOL Toll Brothers Inc.
Toll Brothers is the leading luxury homebuilder in the United States with an average sale price well above public competitors'. The company operates in over 60 markets across 24 states and caters to move-up, active-adult, and second-homebuyers. Traditional homebuilding operations represent most of company's revenue. Toll Brothers also builds luxury for-sale and for-rent properties in urban centers across the US. It has its headquarters in Horsham, Pennsylvania.